BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 27155446)

  • 1. Systems immune monitoring in cancer therapy.
    Greenplate AR; Johnson DB; Ferrell PB; Irish JM
    Eur J Cancer; 2016 Jul; 61():77-84. PubMed ID: 27155446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systems-Level Immune Monitoring by Mass Cytometry.
    Lakshmikanth T; Brodin P
    Methods Mol Biol; 2019; 1913():33-48. PubMed ID: 30666597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single-Cell Approaches to Profile the Response to Immune Checkpoint Inhibitors.
    Gibellini L; De Biasi S; Porta C; Lo Tartaro D; Depenni R; Pellacani G; Sabbatini R; Cossarizza A
    Front Immunol; 2020; 11():490. PubMed ID: 32265933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune Monitoring of Cancer Patients by Multi-color Flow Cytometry.
    Neo SY; O'Reilly A; Pico de Coaña Y
    Methods Mol Biol; 2019; 1913():49-65. PubMed ID: 30666598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mass cytometry: a powerful tool for dissecting the immune landscape.
    Simoni Y; Chng MHY; Li S; Fehlings M; Newell EW
    Curr Opin Immunol; 2018 Apr; 51():187-196. PubMed ID: 29655022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical applications of monitoring immune status with 90 immune cell subsets in human whole blood by 10-color flow cytometry.
    Wang W; Li H; Zhang L; Jiang W; Shen L; Fan G
    Int J Lab Hematol; 2021 Oct; 43(5):1132-1144. PubMed ID: 33870648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-dimensional single-cell cancer biology.
    Irish JM; Doxie DB
    Curr Top Microbiol Immunol; 2014; 377():1-21. PubMed ID: 24671264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparing Viable Single Cells from Human Tissue and Tumors for Cytomic Analysis.
    Leelatian N; Doxie DB; Greenplate AR; Sinnaeve J; Ihrie RA; Irish JM
    Curr Protoc Mol Biol; 2017 Apr; 118():25C.1.1-25C.1.23. PubMed ID: 28369679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimized workflow for human PBMC multiomic immunosurveillance studies.
    Genge PC; Roll CR; Heubeck AT; Swanson E; Kondza N; Lord C; Weiss M; Hernandez V; Phalen C; Thomson Z; Torgerson TR; Skene PJ; Bumol TF; Reading J
    STAR Protoc; 2021 Dec; 2(4):100900. PubMed ID: 34806044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Applications of Single-Cell Omics in Tumor Immunology.
    Liu J; Qu S; Zhang T; Gao Y; Shi H; Song K; Chen W; Yin W
    Front Immunol; 2021; 12():697412. PubMed ID: 34177965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meeting the challenges of measuring human immune regulation.
    Martino D; Allen K
    J Immunol Methods; 2015 Sep; 424():1-6. PubMed ID: 25956036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macromolecular crowding: chemistry and physics meet biology (Ascona, Switzerland, 10-14 June 2012).
    Foffi G; Pastore A; Piazza F; Temussi PA
    Phys Biol; 2013 Aug; 10(4):040301. PubMed ID: 23912807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of Mass Cytometry to Profile Human T Cell Exhaustion.
    Winkler F; Bengsch B
    Front Immunol; 2019; 10():3039. PubMed ID: 32038613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune monitoring using mass cytometry and related high-dimensional imaging approaches.
    Hartmann FJ; Bendall SC
    Nat Rev Rheumatol; 2020 Feb; 16(2):87-99. PubMed ID: 31892734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimized combinatorial pMHC class II multimer labeling for precision immune monitoring of tumor-specific CD4 T cells in patients.
    Rockinger GA; Guillaume P; Cachot A; Saillard M; Speiser DE; Coukos G; Harari A; Romero PJ; Schmidt J; Jandus C
    J Immunother Cancer; 2020 May; 8(1):. PubMed ID: 32448802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single-cell technologies for monitoring immune systems.
    Chattopadhyay PK; Gierahn TM; Roederer M; Love JC
    Nat Immunol; 2014 Feb; 15(2):128-35. PubMed ID: 24448570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenotyping of tumor infiltrating immune cells using mass-cytometry (CyTOF).
    Maby P; Corneau A; Galon J
    Methods Enzymol; 2020; 632():339-368. PubMed ID: 32000904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive Immune Monitoring of Clinical Trials to Advance Human Immunotherapy.
    Hartmann FJ; Babdor J; Gherardini PF; Amir ED; Jones K; Sahaf B; Marquez DM; Krutzik P; O'Donnell E; Sigal N; Maecker HT; Meyer E; Spitzer MH; Bendall SC
    Cell Rep; 2019 Jul; 28(3):819-831.e4. PubMed ID: 31315057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-Dimensional Immune Monitoring for Chimeric Antigen Receptor T Cell Therapies.
    Sharma S; Quinn D; Melenhorst JJ; Pruteanu-Malinici I
    Curr Hematol Malig Rep; 2021 Feb; 16(1):112-116. PubMed ID: 33449291
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.